On February 24, 2017, investigators gathered for the formal closeout of our Phase 2 study of MDMA-assisted psychotherapy in 23 subjects with chronic PTSD in Boulder, Colorado, led by Principal Investigator Marcela Ot’alora, M.A., L.P.C. The closeout was conducted by Senior Clinical Research Associate Charlotte Harrison, and included a thorough review of the study’s documentation, database, files, and adherence to regulations. All treatment sessions and long-term follow-up interviews for this study have now been completed. The final results are being prepared for publication, which is expected in 2017. Learn more…
